美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD

48.20

+4.269.70%

盤後：49.000.8000+1.66%18:59 EDT

成交量：164.47萬

成交額：7,758.54萬

市值：34.15億

市盈率：-20.21

高：48.35

開：44.92

低：44.45

收：43.94

52周最高：94.90

52周最低：13.22

股本：7,084.18萬

流通股本：5,139.47萬

量比：1.86

換手率：3.20%

股息：- -

股息率：- -

每股收益(TTM):-2.3852

每股收益(LYR):-2.3276

淨資產收益率：-11.86%

總資產收益率：-9.39%

市淨率：2.25

市盈率(LYR):-20.71

資料載入中...

總覽公司新聞資訊公告

1億美元！碩迪生物授權羅氏GLP-1專利

医药魔方Info

BUZZ-在其他肥胖症藥物開發商業績下滑的同時，Structure Therapeutics 公司的業績翻了一番

Structure Therapeutics宣佈啓動口服小分子澱粉樣蛋白A受體激動劑Accg-2671的第一階段臨床研究以治療肥胖症

背景資料-隨着競爭白熱化，減肥藥開發商排隊開發利潤豐厚的市場

Structure Therapeutics宣佈成功完成747.5百萬美元的增資公開發行ADS及預付認股權證，並全面行使承銷商購買附加ADS的選項

減肥藥概念走強，GPCR升逾5%，諾和諾德升逾4%

老虎资讯综合

Structure Therapeutics宣佈增強至6.5億美元的公眾發行定價，涉及ADS和預孖展認購權證

BUZZBUZZ作響的美國股票-特斯拉、華納兄弟探索公司、Netflix

中概股逆勢上漲，碩迪生物升逾110%，比特幣突破9.1萬美元

21世纪经济报道

BUZZ--美國股票走勢-美光、NextEra Energy、Ocular Therapeutix

背景資料-隨着競爭白熱化，減肥藥開發商排隊開發利潤豐厚的市場

Structure 公司的實驗性藥片在研究中顯示可減輕 11% 的體重，股價上漲

Structure Therapeutics公布其每日一次口服小分子GLP-1受體激動劑Aleniglipron的積極頂線數據

BUZZ-Structure Therapeutics 在發布減肥藥物數據前下跌

背景資料-隨着競爭白熱化，減肥藥開發商排隊開發利潤豐厚的市場

結構治療公司第三季度淨虧損為6571.2萬美元

異動解讀 | 減肥藥前景看好，Structure Therapeutics盤中大漲5.05%

背景資料-隨着競爭白熱化，減肥藥開發商排隊開發利潤豐厚的市場

重温稿-美國肥胖症生物技術公司 Metsera 成為諾和、輝瑞競購戰的焦點

四環醫藥(00460)與美國AbaloneBio簽署合作協議，聯合開發新一代減重增肌創新療法，進一步深化GPCR靶點領域佈局

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hant/stock/GPCR/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GPCR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GPCR\",,,,,undefined,":{"symbol":"GPCR","market":"US","secType":"STK","nameCN":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD","latestPrice":48.2,"timestamp":1774987200000,"preClose":43.94,"halted":0,"volume":1644666,"hourTrading":{"tag":"盘后","latestPrice":49,"preClose":48.2,"latestTime":"18:59 EDT","volume":14266,"amount":689597.17,"timestamp":1774997947788,"change":0.8,"changeRate":0.016598,"amplitude":0.016598},"delay":0,"changeRate":0.09695038689121542,"floatShares":51394700,"shares":70841812,"eps":-2.385222,"marketStatus":"未開盤","change":4.26,"latestTime":"03-31 16:00:00 EDT","open":44.92,"high":48.35,"low":44.45,"amount":77585416.32069,"amplitude":0.088757,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.385222,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1775030400000},"marketStatusCode":0,"adr":0,"adrRate":3,"listingDate":1675400400000,"exchange":"NASDAQ","adjPreClose":43.94,"preHourTrading":{"tag":"盘前","latestPrice":44.78,"preClose":43.94,"latestTime":"09:27 EDT","volume":1214,"amount":53904.922718,"timestamp":1774963660060,"change":0.84,"changeRate":0.019117,"amplitude":0.037415},"postHourTrading":{"tag":"盘后","latestPrice":49,"preClose":48.2,"latestTime":"18:59 EDT","volume":14266,"amount":689597.17,"timestamp":1774997947788,"change":0.8,"changeRate":0.016598,"amplitude":0.016598},"volumeRatio":1.859431,"impliedVol":0.6598,"impliedVolPercentile":0.1514},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GPCR\",,,,,undefined,":{"symbol":"GPCR","floatShares":51394700,"roa":"-9.39%","roe":"-11.86%","lyrEps":-2.327592,"volumeRatio":1.859431,"shares":70841812,"dividePrice":0,"high":48.35,"amplitude":0.088757,"preClose":43.94,"low":44.45,"week52Low":13.22,"pbRate":"2.25","week52High":94.9,"institutionHeld":0,"latestPrice":48.2,"eps":-2.385222,"divideRate":0,"volume":1644666,"delay":0,"ttmEps":-2.385222,"open":44.92,"prevYearClose":69.55,"prevWeekClose":45.92,"prevMonthClose":62.98,"prevQuarterClose":69.55,"fiveDayClose":47.04,"twentyDayClose":63.035,"sixtyDayClose":68.12},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GPCR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-26","symbol":"GPCR","fiscalQuarterEnding":"2025/12","expectedEps":-0.35,"name":null,"time":"盤後","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"post","actualEps":-0.49},{"market":"US","date":"2025-11-06","symbol":"GPCR","fiscalQuarterEnding":"2025/09","expectedEps":-0.36,"name":null,"time":"盤後","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-0.37},{"market":"US","date":"2025-08-06","symbol":"GPCR","fiscalQuarterEnding":"2025/06","expectedEps":-0.28,"name":null,"time":"盤後","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":-0.36},{"market":"US","date":"2025-05-08","symbol":"GPCR","fiscalQuarterEnding":"2025/03","expectedEps":-0.24,"name":null,"time":"盤後","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":-0.27},{"market":"US","date":"2025-02-27","symbol":"GPCR","fiscalQuarterEnding":"2024/12","expectedEps":-0.23,"name":null,"time":"盤後","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"post","actualEps":-0.22}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GPCR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GPCR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3529,"buy":0.5882,"hold":0.0588,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5882,"analysts":17,"updateTime":1774584000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GPCR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GPCR","date":"2026-03-30","current":-20.207763,"percent":0.264668,"low":-50.180001,"twenty":-24.781668,"median":-19.417639,"eighty":-10.0113,"high":-5.211405,"avg":-19.276712,"sd":8.677096,"marketCap":3253056007},"quantilePoints":[{"date":"2023-02-03","current":-25.001825,"twenty":-43.272389,"median":-43.272389,"eighty":-32.310051,"marketCap":951294422},{"date":"2023-02-10","current":-22.116999,"twenty":-35.964163,"median":-23.496907,"eighty":-22.21316,"marketCap":841529681},{"date":"2023-02-17","current":-21.285207,"twenty":-24.521021,"median":-22.645883,"eighty":-21.915061,"marketCap":809880847},{"date":"2023-02-24","current":-23.36709,"twenty":-23.715192,"median":-22.645883,"eighty":-21.847749,"marketCap":889094402},{"date":"2023-03-03","current":-25.530709,"twenty":-24.422936,"median":-22.718004,"eighty":-21.972757,"marketCap":971417957},{"date":"2023-03-10","current":-22.636267,"twenty":-24.85566,"median":-22.790125,"eighty":-22.063149,"marketCap":861287334},{"date":"2023-03-17","current":-22.232392,"twenty":-24.422936,"median":-22.70358,"eighty":-22.09392,"marketCap":845920270},{"date":"2023-03-24","current":-21.876596,"twenty":-23.762311,"median":-22.568955,"eighty":-21.891982,"marketCap":832382619},{"date":"2023-03-31","current":-16.960589,"twenty":-23.565181,"median":-22.314128,"eighty":-21.634271,"marketCap":870434396},{"date":"2023-04-06","current":-17.823234,"twenty":-23.376706,"median":-22.232392,"eighty":-21.285207,"marketCap":914706175},{"date":"2023-04-14","current":-17.473898,"twenty":-23.36709,"median":-22.116999,"eighty":-18.643102,"marketCap":896777933},{"date":"2023-04-21","current":-17.210114,"twenty":-23.194,"median":-22.059302,"eighty":-17.623613,"marketCap":883240282},{"date":"2023-04-28","current":-17.815518,"twenty":-23.078607,"median":-21.876596,"eighty":-17.586227,"marketCap":914310203},{"date":"2023-05-05","current":-17.709107,"twenty":-22.982446,"median":-21.689083,"eighty":-17.623613,"marketCap":908849077},{"date":"2023-05-12","current":-17.00755,"twenty":-22.790125,"median":-21.491953,"eighty":-17.586227,"marketCap":956079400},{"date":"2023-05-19","current":-15.32957,"twenty":-22.780509,"median":-20.818827,"eighty":-17.473898,"marketCap":861751761},{"date":"2023-05-26","current":-19.808636,"twenty":-22.761276,"median":-19.808636,"eighty":-17.466769,"marketCap":1113542462},{"date":"2023-06-02","current":-21.830342,"twenty":-22.668962,"median":-20.674586,"eighty":-17.472472,"marketCap":1227192672},{"date":"2023-06-09","current":-23.110075,"twenty":-22.668962,"median":-21.38858,"eighty":-17.563702,"marketCap":1299132872},{"date":"2023-06-16","current":-21.061141,"twenty":-22.668962,"median":-21.491953,"eighty":-17.586212,"marketCap":1183952020},{"date":"2023-06-23","current":-21.782692,"twenty":-22.640113,"median":-21.568882,"eighty":-17.608538,"marketCap":1224514048},{"date":"2023-06-30","current":-27.561913,"twenty":-22.772816,"median":-21.571672,"eighty":-17.623492,"marketCap":1549392931},{"date":"2023-07-07","current":-24.451072,"twenty":-23.059375,"median":-21.612515,"eighty":-17.625039,"marketCap":1374517018},{"date":"2023-07-14","current":-21.428724,"twenty":-23.103781,"median":-21.707815,"eighty":-17.644282,"marketCap":1204615694},{"date":"2023-07-21","current":-23.069233,"twenty":-23.103781,"median":-21.780436,"eighty":-17.700571,"marketCap":1296836908},{"date":"2023-07-28","current":-23.552536,"twenty":-23.333385,"median":-21.782692,"eighty":-17.727736,"marketCap":1324005814},{"date":"2023-08-04","current":-21.592094,"twenty":-23.51737,"median":-21.782692,"eighty":-17.804907,"marketCap":1213799550},{"date":"2023-08-11","current":-19.978813,"twenty":-23.374783,"median":-21.781564,"eighty":-17.817061,"marketCap":1123108978},{"date":"2023-08-18","current":-16.072919,"twenty":-23.333385,"median":-21.735043,"eighty":-17.644282,"marketCap":1053531639},{"date":"2023-08-25","current":-16.66259,"twenty":-23.197654,"median":-21.646551,"eighty":-17.586168,"marketCap":1092182818},{"date":"2023-09-01","current":-16.458249,"twenty":-23.185384,"median":-21.592094,"eighty":-17.468195,"marketCap":1078788845},{"date":"2023-09-08","current":-16.680105,"twenty":-23.150918,"median":-21.568882,"eighty":-17.319402,"marketCap":1093330873},{"date":"2023-09-15","current":-18.326514,"twenty":-23.110075,"median":-21.460338,"eighty":-17.211393,"marketCap":1201248026},{"date":"2023-09-22","current":-19.937893,"twenty":-23.078607,"median":-21.067948,"eighty":-17.309925,"marketCap":1306869070},{"date":"2023-09-29","current":-21.876218,"twenty":-23.069233,"median":-21.012104,"eighty":-17.319402,"marketCap":1433920470},{"date":"2023-10-06","current":-37.165618,"twenty":-23.194,"median":-21.285207,"eighty":-17.395476,"marketCap":2436094784},{"date":"2023-10-13","current":-44.162453,"twenty":-23.552536,"median":-21.525005,"eighty":-17.459473,"marketCap":2894716299},{"date":"2023-10-20","current":-45.222784,"twenty":-23.852048,"median":-21.571672,"eighty":-17.466769,"marketCap":2964217822},{"date":"2023-10-27","current":-47.275909,"twenty":-23.892891,"median":-21.592094,"eighty":-17.469621,"marketCap":3098794020},{"date":"2023-11-03","current":-48.538851,"twenty":-24.328544,"median":-21.646551,"eighty":-17.490333,"marketCap":3181576088},{"date":"2023-11-10","current":-38.273225,"twenty":-24.864943,"median":-21.735043,"eighty":-17.514986,"marketCap":2508695101},{"date":"2023-11-17","current":-27.570058,"twenty":-25.04304,"median":-21.781564,"eighty":-17.543453,"marketCap":2122673903},{"date":"2023-11-24","current":-32.691508,"twenty":-27.365869,"median":-21.782692,"eighty":-17.586168,"marketCap":2516984612},{"date":"2023-12-01","current":-35.337541,"twenty":-28.3175,"median":-21.830342,"eighty":-17.593664,"marketCap":2720707940},{"date":"2023-12-08","current":-37.983573,"twenty":-33.138225,"median":-21.904522,"eighty":-17.623452,"marketCap":2924431267},{"date":"2023-12-15","current":-37.177707,"twenty":-34.105722,"median":-22.049686,"eighty":-17.625039,"marketCap":2862386033},{"date":"2023-12-22","current":-20.939825,"twenty":-34.105722,"median":-22.001606,"eighty":-17.644282,"marketCap":1612198995},{"date":"2023-12-29","current":-23.446258,"twenty":-34.065552,"median":-22.068918,"eighty":-17.684898,"marketCap":1805174329},{"date":"2024-01-05","current":-26.187472,"twenty":-34.000259,"median":-22.102574,"eighty":-17.702705,"marketCap":2016225834},{"date":"2024-01-12","current":-28.789086,"twenty":-33.67371,"median":-22.232392,"eighty":-17.746366,"marketCap":2216529345},{"date":"2024-01-19","current":-27.710368,"twenty":-33.290514,"median":-22.259189,"eighty":-17.804907,"marketCap":2133476670},{"date":"2024-01-26","current":-26.745867,"twenty":-33.138225,"median":-22.283013,"eighty":-17.817061,"marketCap":2059217807},{"date":"2024-02-02","current":-28.598724,"twenty":-32.691508,"median":-22.44298,"eighty":-17.823234,"marketCap":2201872991},{"date":"2024-02-09","current":-29.823387,"twenty":-32.667396,"median":-22.576119,"eighty":-17.835432,"marketCap":2296162205},{"date":"2024-02-16","current":-28.427399,"twenty":-32.293017,"median":-22.636267,"eighty":-17.890184,"marketCap":2188682272},{"date":"2024-02-23","current":-26.035182,"twenty":-31.181303,"median":-22.647193,"eighty":-17.91403,"marketCap":2004500750},{"date":"2024-03-01","current":-25.743294,"twenty":-31.092467,"median":-22.775115,"eighty":-17.959972,"marketCap":1982027673},{"date":"2024-03-08","current":-22.849791,"twenty":-30.933832,"median":-22.849791,"eighty":-18.031985,"marketCap":1759251085},{"date":"2024-03-15","current":-18.291889,"twenty":-29.823387,"median":-22.775115,"eighty":-18.031985,"marketCap":1639319082},{"date":"2024-03-22","current":-22.815466,"twenty":-29.601298,"median":-22.761276,"eighty":-18.070517,"marketCap":2044722039},{"date":"2024-03-28","current":-22.311113,"twenty":-29.398245,"median":-22.645883,"eighty":-18.070517,"marketCap":1999521939},{"date":"2024-04-05","current":-20.434088,"twenty":-29.301795,"median":-22.601624,"eighty":-18.089549,"marketCap":1831303011},{"date":"2024-04-12","current":-20.928042,"twenty":-29.107626,"median":-22.568955,"eighty":-18.098906,"marketCap":1875571150},{"date":"2024-04-19","current":-18.81184,"twenty":-29.061939,"median":-22.455039,"eighty":-18.224405,"marketCap":1685917123},{"date":"2024-04-26","current":-20.267704,"twenty":-28.863962,"median":-22.311113,"eighty":-18.256547,"marketCap":1816391638},{"date":"2024-05-03","current":-20.281918,"twenty":-28.794162,"median":-22.289169,"eighty":-18.270537,"marketCap":1817665530},{"date":"2024-05-10","current":-20.105056,"twenty":-28.789086,"median":-22.270856,"eighty":-18.288305,"marketCap":1801815151},{"date":"2024-05-17","current":-17.123915,"twenty":-28.636796,"median":-22.232392,"eighty":-18.098906,"marketCap":1672681180},{"date":"2024-05-24","current":-18.288418,"twenty":-28.476893,"median":-22.116999,"eighty":-18.062811,"marketCap":1786430959},{"date":"2024-05-31","current":-16.11295,"twenty":-28.435013,"median":-22.068918,"eighty":-17.902107,"marketCap":1573929112},{"date":"2024-06-07","current":-26.55105,"twenty":-28.381712,"median":-22.102574,"eighty":-17.902107,"marketCap":2593533072},{"date":"2024-06-14","current":-24.646705,"twenty":-28.337752,"median":-22.198735,"eighty":-17.932407,"marketCap":2407514791},{"date":"2024-06-21","current":-22.312809,"twenty":-28.3175,"median":-22.24579,"eighty":-17.974375,"marketCap":2179537500},{"date":"2024-06-28","current":-18.680713,"twenty":-28.3175,"median":-22.24579,"eighty":-18.00318,"marketCap":1824750754},{"date":"2024-07-05","current":-17.874111,"twenty":-28.267548,"median":-22.198735,"eighty":-17.932407,"marketCap":1745961056},{"date":"2024-07-12","current":-20.408464,"twenty":-28.068249,"median":-22.08815,"eighty":-17.932407,"marketCap":1993519219},{"date":"2024-07-15","current":-20.943017,"twenty":-28.006064,"median":-22.078534,"eighty":-17.941595,"marketCap":2045734877},{"date":"2024-08-02","current":-17.387286,"twenty":-27.943879,"median":-22.068918,"eighty":-17.908069,"marketCap":1698407510},{"date":"2024-08-09","current":-16.461364,"twenty":-27.802578,"median":-21.942986,"eighty":-17.823234,"marketCap":1607962532},{"date":"2024-08-16","current":-20.792004,"twenty":-27.780694,"median":-21.876596,"eighty":-17.821691,"marketCap":2088244945},{"date":"2024-08-23","current":-22.295452,"twenty":-27.74971,"median":-21.929398,"eighty":-17.823234,"marketCap":2239243758},{"date":"2024-08-30","current":-21.822777,"twenty":-27.716713,"median":-21.953525,"eighty":-17.863936,"marketCap":2191770646},{"date":"2024-09-06","current":-21.851252,"twenty":-27.691332,"median":-21.926349,"eighty":-17.874111,"marketCap":2194630472},{"date":"2024-09-13","current":-22.944669,"twenty":-27.671026,"median":-21.901472,"eighty":-17.880178,"marketCap":2304447790},{"date":"2024-09-20","current":-22.067657,"twenty":-27.608415,"median":-21.926349,"eighty":-17.902107,"marketCap":2216365150},{"date":"2024-09-27","current":-23.650834,"twenty":-27.565171,"median":-22.001606,"eighty":-17.941595,"marketCap":2375371475},{"date":"2024-10-04","current":-24.083644,"twenty":-27.536769,"median":-22.068918,"eighty":-18.000093,"marketCap":2418840830},{"date":"2024-10-11","current":-22.130301,"twenty":-27.481934,"median":-22.12365,"eighty":-18.029927,"marketCap":2222656767},{"date":"2024-10-18","current":-22.563112,"twenty":-27.163394,"median":-22.116999,"eighty":-18.055104,"marketCap":2266126122},{"date":"2024-10-25","current":-21.333018,"twenty":-26.967956,"median":-22.11226,"eighty":-18.070517,"marketCap":2142581639},{"date":"2024-10-31","current":-21.560813,"twenty":-26.932422,"median":-22.097835,"eighty":-18.080033,"marketCap":2165460247},{"date":"2024-11-08","current":-21.839862,"twenty":-26.875803,"median":-22.107521,"eighty":-18.096607,"marketCap":2193486542},{"date":"2024-11-15","current":-19.500107,"twenty":-26.820843,"median":-22.068288,"eighty":-18.16223,"marketCap":2155736838},{"date":"2024-11-22","current":-15.573182,"twenty":-26.740791,"median":-22.039183,"eighty":-18.047398,"marketCap":1721615252},{"date":"2024-11-29","current":-17.170432,"twenty":-26.702879,"median":-21.932448,"eighty":-17.923218,"marketCap":1898191276},{"date":"2024-12-06","current":-16.181125,"twenty":-26.575564,"median":-21.883856,"eighty":-17.833409,"marketCap":1788823393},{"date":"2024-12-13","current":-16.424567,"twenty":-26.524021,"median":-21.851252,"eighty":-17.817061,"marketCap":1815735909},{"date":"2024-12-20","current":-15.523314,"twenty":-26.386717,"median":-21.835102,"eighty":-17.715324,"marketCap":1716102339},{"date":"2024-12-27","current":-15.30059,"twenty":-26.269962,"median":-21.822777,"eighty":-17.687076,"marketCap":1691480250},{"date":"2025-01-03","current":-14.601342,"twenty":-26.20397,"median":-21.78933,"eighty":-17.625803,"marketCap":1614178343},{"date":"2025-01-10","current":-14.005686,"twenty":-26.17605,"median":-21.782692,"eighty":-17.604018,"marketCap":1548328570},{"date":"2025-01-17","current":-13.974608,"twenty":-26.160821,"median":-21.780436,"eighty":-17.514986,"marketCap":1544892930},{"date":"2025-01-24","current":-14.482211,"twenty":-26.10752,"median":-21.737354,"eighty":-17.469621,"marketCap":1601008389},{"date":"2025-01-31","current":-15.7046,"twenty":-26.035182,"median":-21.700984,"eighty":-17.381485,"marketCap":1736143575},{"date":"2025-02-07","current":-15.549212,"twenty":-26.032644,"median":-21.680405,"eighty":-17.295679,"marketCap":1718965373},{"date":"2025-02-14","current":-12.622728,"twenty":-25.9819,"median":-21.605123,"eighty":-17.234446,"marketCap":1395442576},{"date":"2025-02-21","current":-12.115125,"twenty":-25.903236,"median":-21.581883,"eighty":-17.21037,"marketCap":1339327118},{"date":"2025-02-28","current":-11.819887,"twenty":-25.84482,"median":-21.567582,"eighty":-17.171628,"marketCap":1306688535},{"date":"2025-03-07","current":-11.01217,"twenty":-25.735679,"median":-21.559435,"eighty":-17.124089,"marketCap":1349277189},{"date":"2025-03-14","current":-9.547313,"twenty":-25.689992,"median":-21.491953,"eighty":-17.045645,"marketCap":1169794078},{"date":"2025-03-21","current":-10.235281,"twenty":-25.609403,"median":-21.417887,"eighty":-16.960589,"marketCap":1254088063},{"date":"2025-03-28","current":-9.33203,"twenty":-25.527539,"median":-21.321628,"eighty":-16.93886,"marketCap":1143416369},{"date":"2025-04-04","current":-7.64253,"twenty":-25.480594,"median":-21.202701,"eighty":-16.831205,"marketCap":936408691},{"date":"2025-04-11","current":-7.043483,"twenty":-25.340669,"median":-21.061141,"eighty":-16.666093,"marketCap":863009847},{"date":"2025-04-17","current":-8.672143,"twenty":-25.329214,"median":-21.042579,"eighty":-16.563339,"marketCap":1062562954},{"date":"2025-04-25","current":-11.068331,"twenty":-25.25285,"median":-20.951128,"eighty":-16.426861,"marketCap":1356158331},{"date":"2025-05-02","current":-12.790591,"twenty":-25.171712,"median":-20.933479,"eighty":-16.305436,"marketCap":1567180008},{"date":"2025-05-09","current":-12.551909,"twenty":-25.070517,"median":-20.891345,"eighty":-16.181125,"marketCap":1537935156},{"date":"2025-05-16","current":-9.774326,"twenty":-25.068859,"median":-20.829252,"eighty":-16.056814,"marketCap":1400885752},{"date":"2025-05-23","current":-9.895696,"twenty":-25.0453,"median":-20.693431,"eighty":-15.839386,"marketCap":1418280862},{"date":"2025-05-30","current":-9.000467,"twenty":-25.01052,"median":-20.672234,"eighty":-15.745511,"marketCap":1289973912},{"date":"2025-06-06","current":-8.619091,"twenty":-25.001825,"median":-20.550917,"eighty":-15.544032,"marketCap":1235314001},{"date":"2025-06-13","current":-8.920177,"twenty":-24.996225,"median":-20.487391,"eighty":-15.387426,"marketCap":1278466562},{"date":"2025-06-20","current":-8.679308,"twenty":-24.952868,"median":-20.449033,"eighty":-14.973238,"marketCap":1243944513},{"date":"2025-06-27","current":-8.462526,"twenty":-24.918331,"median":-20.434088,"eighty":-14.66039,"marketCap":1212874668},{"date":"2025-07-03","current":-8.175491,"twenty":-24.875783,"median":-20.408464,"eighty":-14.607558,"marketCap":1171735893},{"date":"2025-07-11","current":-7.587369,"twenty":-24.818526,"median":-20.385744,"eighty":-14.451133,"marketCap":1087444556},{"date":"2025-07-18","current":-7.840282,"twenty":-24.807686,"median":-20.281918,"eighty":-14.123781,"marketCap":1123692707},{"date":"2025-07-25","current":-7.334457,"twenty":-24.781668,"median":-20.180483,"eighty":-13.987039,"marketCap":1051196404},{"date":"2025-08-01","current":-7.145777,"twenty":-24.722332,"median":-20.085721,"eighty":-13.108576,"marketCap":1024154132},{"date":"2025-08-08","current":-5.211405,"twenty":-24.651853,"median":-19.971704,"eighty":-12.812535,"marketCap":932580977},{"date":"2025-08-15","current":-5.964179,"twenty":-24.61951,"median":-19.937893,"eighty":-12.626872,"marketCap":1067289809},{"date":"2025-08-22","current":-6.234546,"twenty":-24.540145,"median":-19.829477,"eighty":-12.490132,"marketCap":1115672078},{"date":"2025-08-29","current":-6.160517,"twenty":-24.4698,"median":-19.66456,"eighty":-12.119485,"marketCap":1102424552},{"date":"2025-09-05","current":-6.360074,"twenty":-24.389808,"median":-19.576169,"eighty":-11.77845,"marketCap":1138135274},{"date":"2025-09-12","current":-6.720564,"twenty":-24.139365,"median":-19.456275,"eighty":-11.057099,"marketCap":1202644966},{"date":"2025-09-19","current":-7.47695,"twenty":-24.11098,"median":-19.134734,"eighty":-10.896967,"marketCap":1338000122},{"date":"2025-09-26","current":-8.043434,"twenty":-24.072254,"median":-19.014985,"eighty":-10.567565,"marketCap":1439372495},{"date":"2025-10-03","current":-8.568076,"twenty":-24.020356,"median":-18.941828,"eighty":-10.325716,"marketCap":1533257136},{"date":"2025-10-10","current":-9.833009,"twenty":-23.986828,"median":-18.81071,"eighty":-10.186609,"marketCap":1759617036},{"date":"2025-10-17","current":-8.87063,"twenty":-23.947347,"median":-18.74276,"eighty":-9.917033,"marketCap":1587399198},{"date":"2025-10-24","current":-8.548764,"twenty":-23.914099,"median":-18.661907,"eighty":-9.852324,"marketCap":1529801259},{"date":"2025-10-31","current":-10.370526,"twenty":-23.886602,"median":-18.351918,"eighty":-9.836476,"marketCap":1855805594},{"date":"2025-11-07","current":-10.772858,"twenty":-23.868757,"median":-18.327399,"eighty":-9.850579,"marketCap":1927803018},{"date":"2025-11-14","current":-10.08006,"twenty":-23.852048,"median":-18.288418,"eighty":-9.817863,"marketCap":2123717400},{"date":"2025-11-21","current":-9.889979,"twenty":-23.841601,"median":-18.256152,"eighty":-9.836476,"marketCap":2083670157},{"date":"2025-11-28","current":-10.313341,"twenty":-23.799814,"median":-18.097181,"eighty":-9.841018,"marketCap":2172866288},{"date":"2025-12-05","current":-9.460856,"twenty":-23.776121,"median":-18.070517,"eighty":-9.814076,"marketCap":1993260474},{"date":"2025-12-12","current":-19.422835,"twenty":-23.650834,"median":-18.082412,"eighty":-9.833009,"marketCap":4092100041},{"date":"2025-12-19","current":-17.985707,"twenty":-23.62393,"median":-18.070517,"eighty":-9.841018,"marketCap":3789318618},{"date":"2025-12-26","current":-22.869735,"twenty":-23.621272,"median":-18.100056,"eighty":-9.848479,"marketCap":4818310220},{"date":"2026-01-02","current":-22.823793,"twenty":-23.615623,"median":-18.255492,"eighty":-9.851048,"marketCap":4808630734},{"date":"2026-01-09","current":-21.980412,"twenty":-23.576442,"median":-18.281194,"eighty":-9.851517,"marketCap":4630943013},{"date":"2026-01-16","current":-27.900487,"twenty":-23.621936,"median":-18.326514,"eighty":-9.853937,"marketCap":5878214018},{"date":"2026-01-23","current":-30.148409,"twenty":-23.790337,"median":-18.349084,"eighty":-9.86147,"marketCap":6351817477},{"date":"2026-01-30","current":-28.599475,"twenty":-23.883185,"median":-18.63625,"eighty":-9.874048,"marketCap":6025480495},{"date":"2026-02-06","current":-24.024872,"twenty":-24.012922,"median":-18.680713,"eighty":-9.881446,"marketCap":5061680173},{"date":"2026-02-13","current":-23.64092,"twenty":-24.104146,"median":-18.735704,"eighty":-9.886523,"marketCap":4980787319},{"date":"2026-02-20","current":-22.141212,"twenty":-24.072254,"median":-18.787312,"eighty":-9.891122,"marketCap":4664821216},{"date":"2026-02-27","current":-21.248606,"twenty":-24.026331,"median":-18.905431,"eighty":-9.903769,"marketCap":4476762617},{"date":"2026-03-06","current":-29.951815,"twenty":-24.389808,"median":-18.958825,"eighty":-9.939515,"marketCap":4229256176},{"date":"2026-03-13","current":-27.383083,"twenty":-24.63457,"median":-19.091174,"eighty":-9.953915,"marketCap":3866546098},{"date":"2026-03-20","current":-25.316057,"twenty":-24.813106,"median":-19.247915,"eighty":-9.965451,"marketCap":3574677833},{"date":"2026-03-27","current":-23.178791,"twenty":-24.786548,"median":-19.412443,"eighty":-10.00684,"marketCap":3272891714},{"date":"2026-03-30","current":-23.038314,"twenty":-24.781668,"median":-19.417639,"eighty":-10.0113,"marketCap":3253056007}],"updateTime":1775016874014},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GPCR\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2601127868","title":"1億美元！碩迪生物授權羅氏GLP-1專利","url":"https://stock-news.laohu8.com/highlight/detail?id=2601127868","media":"医药魔方Info","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601127868?lang=zh_tw&edition=fundamental","pubTime":"2026-01-06 15:41","pubTimestamp":1767685313,"startTime":"0","endTime":"0","summary":"2025年12月30日，Structure Therapeutics通过其子公司Gasherbrum Bio与罗氏和基因泰克达成了一项非独家专利许可协议，并获得了1亿美元的预付款。若一方出现重大违约且未能纠正，或基因泰克对授权专利的有效性提出质疑，硕迪生物均有权终止本协议。这笔1亿美元的现金注入，为硕迪生物带来了非稀释性资金，可助力其在竞争激烈的GLP-1赛道推进临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106155205a4a258bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106155205a4a258bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GLP","GPCR","BK4144","BK4599","BK4590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595777671","title":"BUZZ-在其他肥胖症藥物開發商業績下滑的同時，Structure Therapeutics 公司的業績翻了一番","url":"https://stock-news.laohu8.com/highlight/detail?id=2595777671","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595777671?lang=zh_tw&edition=fundamental","pubTime":"2025-12-31 22:29","pubTimestamp":1767191377,"startTime":"0","endTime":"0","summary":"BUZZ-在其他肥胖症药物开发商业绩下滑的同时，Structure Therapeutics 公司的业绩翻了一番12月31日 - ** Structure Therapeutics GPCR.O的股价在2024年下跌33%之后，今年已经翻了一番多。** Altimmune 的股价今年已下跌 49.9%，将连续第三年下跌。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251231:nL4T3Y10LZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2746668974.SGD","LU0256863902.USD","IE00BN29S564.USD","SG9999014906.USD","LU1064131342.USD","BK4139","SGXZ57979304.SGD","LU0353189680.USD","IE00B4R5TH58.HKD","LU0320765059.SGD","LU1983299246.USD","LU2168563687.JPY","IE00BWXC8680.SGD","LU2471134523.USD","LU2491049909.HKD","BK4581","LU1868837300.USD","IE00B775H168.HKD","IE0004445239.USD","LU2211815571.USD","LU0289739699.SGD","IE0005OL40V9.USD","BK4588","IE00BFSS8Q28.SGD","LU2023250504.SGD","SG9999015952.SGD","LU1720051017.SGD","LU2746668461.USD","BK4599","LU0466842654.USD","LU1989771016.USD","LU2361044865.SGD","IE00BJT1NW94.SGD","LU2491050071.SGD","GPCR","SG9999014898.SGD","IE00B1XK9C88.USD","LU2106854487.HKD","LU0417517546.SGD","LU2361044949.HKD","LU2265009873.SGD","SG9999015986.USD","LU0198837287.USD","LU1720051108.HKD","LU2361045086.USD","IE00B7KXQ091.USD","LU1548497426.USD","LU0106261372.USD","LU1814569148.SGD","LU2417539215.USD","IE00BJLML261.HKD","LU0203201768.USD","LU2471134952.CNY","LU1868836914.USD","LU0786609619.USD","LU2236285917.USD","LU0097036916.USD","LU1023059063.AUD","LU2471134796.USD","IE00B2B36J28.USD","BK4516","LU0820561909.HKD","LU2456880835.USD","LU2552382132.HKD","LU0823434740.USD","GB00BDT5M118.USD","LU0882574139.USD","LU2602419157.SGD","LU1878469433.USD","LU1988902786.USD","SG9999001176.USD","LU0109394709.USD","SG9999013999.USD","IE00BK4W5M84.HKD","SG9999018857.SGD","IE00B1BXHZ80.USD","IE00BK4W5L77.USD","LU0683600562.USD","LU2237443549.SGD","LU2552382215.SGD","SG9999001176.SGD","LU0708995401.HKD","LU1127390331.HKD","SGXZ31699556.SGD","LU0820561818.USD","LU2357305700.SGD","LU1551013425.SGD","LU0456855351.SGD","IE00BJJMRY28.SGD","LU1804176565.USD","LU2552382058.USD","BK4533","SGXZ99366536.SGD","SGXZ51526630.SGD","LU0823434583.USD","LU1623119135.USD","LU0640476718.USD","LU2168564222.USD","LU0203202063.USD","LU0471298777.SGD","LU2324357040.USD","BK4007","LU1280957306.USD","LU1093756325.SGD","LU0320765992.SGD","IE0002141913.USD","LU0266013472.USD","IE0009355771.USD","IE00B4JS1V06.HKD","LU2089984988.USD","LU2237443382.USD","SG9999014880.SGD","LU0094547139.USD","LU1069344957.HKD","LU1057294990.SGD","LU1291159041.SGD","SG9999015978.USD","LU0323591593.USD","LU2168564065.EUR","LU0689472784.USD","LU0823416689.USD","LU2237438978.USD","LU0256863811.USD","SG9999017495.SGD","LU0006306889.USD","LU1868836757.USD","BK4585","SG9999015945.SGD","IE00BFSS7M15.SGD","IE00BJJMRX11.SGD","LU1061106388.HKD","LU0079474960.USD","IE0004445015.USD","LU0109391861.USD","LU0122379950.USD","LU0889565916.HKD","LU2168564149.EUR","LU2461242641.AUD","LU2750360641.GBP","LU0672654240.SGD","LU1267930730.SGD","LU1232071149.USD","LU2468319806.SGD","LU0058720904.USD","LU2237443978.SGD","LU1035775433.USD","LU2063271972.USD","LU1868837136.USD","LU0471298694.HKD","LU2264538146.SGD","LU0096364046.USD","LU0353189763.USD","LU2491050154.USD","LU0234572021.USD","LU0114720955.EUR","LU0432979614.USD","LU1917777945.USD","SGXZ81514606.USD","SG9999018865.SGD","LU2237443895.HKD","LU2237443465.HKD","LU2750360997.AUD","LU1366192091.USD","LU2471134879.HKD","LU2108987350.USD","LU0943347566.SGD","IE00BKPKM429.USD","LU2168564495.EUR","LU1712237335.SGD","IE00BJJMRZ35.SGD","LU1551013342.USD","LU2237443622.USD","BK4534","LU0238689110.USD","LU2360106947.USD","LU2462157665.USD","LU2087625088.SGD","LU0354030511.USD","LU1974910355.USD","LU1323610961.USD","SG9999014914.USD","LU0316494557.USD","LU2112291526.USD","LU0061475181.USD","LU1868836591.USD","LU0385154629.USD","LU0882574055.USD","IE00BFTCPJ56.SGD","IE00BKDWB100.SGD","LU1093756168.USD","LU0787776722.HKD","LU0354030438.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194056049","title":"Structure Therapeutics宣佈啓動口服小分子澱粉樣蛋白A受體激動劑Accg-2671的第一階段臨床研究以治療肥胖症","url":"https://stock-news.laohu8.com/highlight/detail?id=1194056049","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194056049?lang=zh_tw&edition=fundamental","pubTime":"2025-12-17 21:32","pubTimestamp":1765978346,"startTime":"0","endTime":"0","summary":"Structure Therapeutics宣布启动口服小分子淀粉样蛋白A受体激动剂Accg-2671的第一阶段临床研究以治疗肥胖症","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GPCR","BK4599","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590505938","title":"背景資料-隨着競爭白熱化，減肥藥開發商排隊開發利潤豐厚的市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2590505938","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590505938?lang=zh_tw&edition=fundamental","pubTime":"2025-12-12 20:04","pubTimestamp":1765541053,"startTime":"0","endTime":"0","summary":"背景资料-随着竞争白热化，减肥药开发商排队开发利润丰厚的市场修改日期线，在第 19、20、27、36 和 54 段增加新的细节。今年8月，该制药公司称其试验性减肥药orforglipron ，在一项晚期试验中，以36毫克的最高剂量服用72周，可帮助患有2型糖尿病的超重成年人减轻10.5%的体重。服用最高剂量Ozempic的糖尿病患者体重大约减轻了6%。礼来公司希望在今年年底前获得监管部门对orfglipron的批准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nL4S3XI0UM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0784383803.USD","VKTX","LU0345777659.USD","MRK","LU0203345920.USD","LU0575583348.USD","02105","GPCR","LU0310800379.SGD","LU1917777945.USD","LU0949170772.SGD","LU1037948897.HKD","00656","LU2023250504.SGD","IE00BFTCPJ56.SGD","IE0002141913.USD","LU0208291251.USD","LU0234572021.USD","LU0689472784.USD","LU2237443622.USD","BK4588","LU1084165304.USD","LU1066051811.HKD","03933","LU2114397693.USD","PFE","LU0058720904.USD","MTSR","LU0969580561.USD","LLY","LU1551013425.SGD","600196","03692","ALT","LU1003076772.USD","LU1057294990.SGD","LU1894683348.USD","LU0786609619.USD","03165","LU2361044865.SGD","LU2491050154.USD","BK0183","SG9999014914.USD","AZN.UK","OPK","LU1989772923.USD","SRRK","LU1116320901.HKD","AMGN","LU1929549753.HKD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1151839452","title":"Structure Therapeutics宣佈成功完成747.5百萬美元的增資公開發行ADS及預付認股權證，並全面行使承銷商購買附加ADS的選項","url":"https://stock-news.laohu8.com/highlight/detail?id=1151839452","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151839452?lang=zh_tw&edition=fundamental","pubTime":"2025-12-12 05:02","pubTimestamp":1765486953,"startTime":"0","endTime":"0","summary":"Structure Therapeutics宣布成功完成747.5百万美元的增资公开发行ADS及预付认股权证，并全面行使承销商购买附加ADS的选项。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GPCR","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169452002","title":"減肥藥概念走強，GPCR升逾5%，諾和諾德升逾4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1169452002","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169452002?lang=zh_tw&edition=fundamental","pubTime":"2025-12-10 23:26","pubTimestamp":1765380382,"startTime":"0","endTime":"0","summary":"罗氏控股涨超3%，礼来跟涨。","market":"us","thumbnail":"https://static.tigerbbs.com/5680d8f4d3b53955520e696fc46611e4","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5680d8f4d3b53955520e696fc46611e4"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"8c3694a08f44a67f8ee972cef2b11b95","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLY","GPCR","RHHBY","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183719988","title":"Structure Therapeutics宣佈增強至6.5億美元的公眾發行定價，涉及ADS和預孖展認購權證","url":"https://stock-news.laohu8.com/highlight/detail?id=1183719988","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183719988?lang=zh_tw&edition=fundamental","pubTime":"2025-12-10 12:16","pubTimestamp":1765340172,"startTime":"0","endTime":"0","summary":"Structure Therapeutics宣布增强至6.5亿美元的公众发行定价，涉及ADS和预融资认购权证","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GPCR","BK4007","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590352974","title":"BUZZBUZZ作響的美國股票-特斯拉、華納兄弟探索公司、Netflix","url":"https://stock-news.laohu8.com/highlight/detail?id=2590352974","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590352974?lang=zh_tw&edition=fundamental","pubTime":"2025-12-09 00:22","pubTimestamp":1765210942,"startTime":"0","endTime":"0","summary":"nL6N3XE0OV ** NextEra Energy Inc NEE.N:BUZZ - 因谷歌扩大合作关系和 Meta 清洁能源交易而上涨  nL4N3XE0XS ** Ocular Therapeutix Inc OCUL.O:BUZZ - 因计划快速向 FDA 申请眼疾药物而上涨 nL4N3XE1AA ** Kymera Therapeutics Inc KYMR.O:BUZZ - 因湿疹药物数据良好而上涨  nL6N3XE0P9 ** Compass Inc COMP.N:BUZZ - 巴克莱将 Compass 评为 \"增持\"；股价上涨 nL4N3XE0UU ** CoreWeave Inc CRWV.O:BUZZ - 宣布发行 20 亿美元可转换债券；股价下跌 nL6N3XE0PV ** Recursion Pharmaceuticals Inc RXRX.O:BUZZ - 在罕见病试验中，实验性药物减少了息肉的生长，股价上涨   nL4N3XE0VV ** Fulcrum Therapeutics Inc FULC.O:BUZZ - 血液疾病药物试验数据公布后股价跳涨   nL4N3XE19X ** 永利度假村WYNN.O:BUZZ -","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nL4S3XE1FV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WRBY","ACLX","AR","ARE","MHUA","ALB","FIVE","NRIX","FCX","RIO.UK","JEF","RIOT","COMP","INCY","WYNN","GPCR","KYMR","OCUL","FANG","USCB","WVE","RIVN","MHUAF","BHP.AU","LITB","APD","AGIO","EOG","NFLX","GM","MMM","DYN","CETX","JBL","CVNA","SCCO","LEN","TSLA","APA","IBM","CFLT"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2590352124","title":"中概股逆勢上漲，碩迪生物升逾110%，比特幣突破9.1萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2590352124","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590352124?lang=zh_tw&edition=fundamental","pubTime":"2025-12-09 00:13","pubTimestamp":1765210437,"startTime":"0","endTime":"0","summary":"北京时间12月8日晚，美股三大指数高开后翻绿，中概股逆势上涨，黄金白银全线飘绿，比特币短线走高升破91000美元。中概股逆势上涨，中国金龙指数涨约0.3%，虎牙涨近8%，大全新能源涨6.4%，百度集团涨超3%。下跌方面，泡泡玛特美股跌约8%。硕迪生物盘前大涨30%，开盘后一路走高，截至发稿涨幅已高达117%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512093585643984.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512093585643984.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["83042","GPCR","BK4601","BK4588","BK1611","BK4585","BTC","BK4594"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589597873","title":"BUZZ--美國股票走勢-美光、NextEra Energy、Ocular Therapeutix","url":"https://stock-news.laohu8.com/highlight/detail?id=2589597873","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589597873?lang=zh_tw&edition=fundamental","pubTime":"2025-12-08 22:34","pubTimestamp":1765204460,"startTime":"0","endTime":"0","summary":"12月8日 - 美国股指期货周一小幅走高，原因是投资者认为美联储将在本周晚些时候举行期待已久的降息会议，而这次会议将是多年来分歧最大的会议之一。** Incyte Corp INCY.O:BUZZ - 抗体疗法在罕见血癌中显示出潜力后上涨 [完整报道 ]** Structure Therapeutics Inc GPCR.O:BUZZ - 减肥药物中期试验成功后上涨 [完整报道 ]。** Ocular Therapeutix Inc OCUL.O:BUZZ - 因计划快速向 FDA 申请眼疾药物而上涨 [完整报道 ]。** Kymera Therapeutics Inc KYMR.O:BUZZ - 因湿疹药物数据良好而上涨 [全文 ]。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nL4S3XE16L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GPCR","FANG","OCUL","USCB","WYNN","LEN","DYN","RIO.UK","INCY","RIO.AU","COP","ALB","HUT","LU0124676726.USD","AGIO","SCCO","APA","CVNA","AR","LU1032955483.USD","NEE","IBM","GM","CRH","FULC","MU","TSYW.SI","RIOT","KYMR","BK4511","CFLT","COMP","EOG","ACLX","BHP.AU","MMM","WVE","FCX","JEF"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2589535914","title":"背景資料-隨着競爭白熱化，減肥藥開發商排隊開發利潤豐厚的市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2589535914","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589535914?lang=zh_tw&edition=fundamental","pubTime":"2025-12-08 22:29","pubTimestamp":1765204182,"startTime":"0","endTime":"0","summary":"背景资料-随着竞争白热化，减肥药开发商排队开发利润丰厚的市场更改日期线，重写标题，增加有关 Structure Therapeutics 公司最新数据的详细信息。诺和诺德计划在 2026 年第一季度将 CagriSema 提交监管部门审批。今年 9 月，MET-097i 在两项中期试验中显示，28 周后平均体重下降 14.1%。服用最高剂量Ozempic的糖尿病患者大约减轻了6%的体重。西兰制药 丹麦生物技术公司西兰制药ZELA.CO去年表示，在一项早期研究中，其减肥候选药物petrelintide的高剂量在每周服用16次后，体重平均减轻了8.6%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nL4T3XE15C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1104425308.USD","LU1267930813.SGD","SG9999017495.SGD","IE00B3T34201.USD","LU0786609619.USD","02105","GPCR","LU1934455863.HKD","SG9999018865.SGD","ALT","SRRK","LU0784385170.HKD","LU1496350502.SGD","VKTX","MTSR","LU0238689110.USD","LU0889565916.HKD","LU0823416689.USD","OPK","03933","IE0002270589.USD","LU1261432733.SGD","BK1191","AMGN","03165","LU2491050154.USD","MRK","BK4196","LU2471134523.USD","LU0943347566.SGD","IE0005OL40V9.USD","SG9999003800.SGD","LU1037948897.HKD","AZN.UK","LU0456855351.SGD","LU1974910355.USD","IE0034235188.USD","LU0889565080.SGD","LU0960981461.USD","SG9999014559.SGD","IE00BN8TJ469.HKD","LU1623119135.USD","LU2023251221.USD","LU2471134952.CNY","LU1232071149.USD","03692","LU0672654240.SGD","BK1583"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2589535293","title":"Structure 公司的實驗性藥片在研究中顯示可減輕 11% 的體重，股價上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2589535293","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589535293?lang=zh_tw&edition=fundamental","pubTime":"2025-12-08 21:04","pubTimestamp":1765199094,"startTime":"0","endTime":"0","summary":"Structure 公司的实验性药片在研究中显示可减轻 11% 的体重，股价上涨路透12月8日 - Structure Therapeutics GPCR.O周一表示，其肥胖药片在一项中期研究中显示体重下降了11.3%。这家生物技术公司的股票在盘前交易中大涨41.8%。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nL4T3XE0XD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GPCR","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158075123","title":"Structure Therapeutics公布其每日一次口服小分子GLP-1受體激動劑Aleniglipron的積極頂線數據","url":"https://stock-news.laohu8.com/highlight/detail?id=1158075123","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158075123?lang=zh_tw&edition=fundamental","pubTime":"2025-12-08 21:02","pubTimestamp":1765198975,"startTime":"0","endTime":"0","summary":"Structure Therapeutics公布其每日一次口服小分子GLP-1受体激动剂Aleniglipron的积极顶线数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4599","GPCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589337622","title":"BUZZ-Structure Therapeutics 在發布減肥藥物數據前下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2589337622","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589337622?lang=zh_tw&edition=fundamental","pubTime":"2025-12-08 19:51","pubTimestamp":1765194682,"startTime":"0","endTime":"0","summary":"12月8日 - ** Structure Therapeutics GPCR.O股价盘前下跌1.4%至34.1美元 ** 该药物开发商将于 12 月 8 日  发布一项研究的数据，该研究评估了其用于治疗肥胖症的每日口服一次的实验性药物 aleniglipron。** 维京治疗公司的试验性减肥药VK2735此前在8月份未能 ，超出了华尔街的预期。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nL4S3XE0RU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","GPCR","VKTX","BK4588","BK4139","BK4007","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586475794","title":"背景資料-隨着競爭白熱化，減肥藥開發商排隊開發利潤豐厚的市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2586475794","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586475794?lang=zh_tw&edition=fundamental","pubTime":"2025-11-25 21:39","pubTimestamp":1764077953,"startTime":"0","endTime":"0","summary":"背景资料-随着竞争白热化，减肥药开发商排队开发利润丰厚的市场改写第1段，在第3段增加礼来估值里程碑，更新第9-0段诺和诺德试验细节。在其中一项试验中，该药帮助超重患者减轻了22.7%的体重，低于诺和诺德25%的预期。诺和诺德计划在 2026 年第一季度将 CagriSema 提交监管部门审批。今年 9 月，MET-097i 在两项中期试验中显示，28 周后平均体重下降 14.1%。服用最高剂量Ozempic的糖尿病患者体重大约减轻了6%。礼来公司希望在今年年底前获得监管部门对orfglipron的批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nL4S3X10WR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN","AZN.UK","LU0109391861.USD","LU0198837287.USD","03692","LU2168564149.EUR","LU0353189680.USD","IE00BLSP4239.USD","LU2063271972.USD","LU1551013342.USD","LLY","03165","BK4592","LU0820561909.HKD","LU0094547139.USD","IE00B4R5TH58.HKD","LU0557290698.USD","SG9999013999.USD","LU0553294199.USD","LU0823416689.USD","ALT","LU0949170772.SGD","03933","LU0225771236.USD","SG9999015986.USD","SG9999014542.SGD","LU2265009873.SGD","GPCR","SRRK","LU2168564065.EUR","LU1023059063.AUD","LU2746668461.USD","LU0964806797.USD","LU0079474960.USD","VKTX","LU0265550359.USD","OPK","LU1069347547.HKD","LU1061106388.HKD","MRK","MTSR","SG9999015945.SGD","LU2168563687.JPY","LU0738911758.USD","LU1057294990.SGD","02105","SG9999011175.SGD","LU1066051225.USD","IE0004445239.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1197191118","title":"結構治療公司第三季度淨虧損為6571.2萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1197191118","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197191118?lang=zh_tw&edition=fundamental","pubTime":"2025-11-20 01:00","pubTimestamp":1763571648,"startTime":"0","endTime":"0","summary":"11月6日讯 - 结构治疗公司第三季度经营支出为7378.7万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GPCR","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158433675","title":"異動解讀 | 減肥藥前景看好，Structure Therapeutics盤中大漲5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=1158433675","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158433675?lang=zh_tw&edition=fundamental","pubTime":"2025-11-10 23:00","pubTimestamp":1762786833,"startTime":"0","endTime":"0","summary":"周一盘中，Structure Therapeutics股价大涨5.05%，引发市场关注。Structure Therapeutics的实验性口服肥胖症药物在去年的一项中期研究中显示出积极结果。该研究表明，在12周的治疗期内，患者平均减轻了6.2%的体重。随着辉瑞、诺和诺德和礼来等制药巨头纷纷进入这一领域，减肥药市场的竞争日益白热化。Structure Therapeutics作为一家专注于开发口服减肥药的公司，其产品如果成功上市，可能会在这个快速增长的市场中占据重要地位。投资者似乎对公司的前景持乐观态度，推动了股价的上涨。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GPCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2582708318","title":"背景資料-隨着競爭白熱化，減肥藥開發商排隊開發利潤豐厚的市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2582708318","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582708318?lang=zh_tw&edition=fundamental","pubTime":"2025-11-10 22:45","pubTimestamp":1762785907,"startTime":"0","endTime":"0","summary":"背景资料-随着竞争白热化，减肥药开发商排队开发利润丰厚的市场改写第1、2段，增加辉瑞与Metsera的交易；更新礼来、罗氏、Viking的信息；在第6-7段增加Metsera肥胖症候选药物的细节，在第42-43段增加Scholar Rock的细节。辉瑞PFE.N收购生物技术公司Metsera有望加速其重新进入利润丰厚的肥胖症治疗市场，目前该市场由礼来LLY.N和丹麦竞争对手诺和诺德NOVOb.CO主导。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nL4S3WM182:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089284900.SGD","LU1267930730.SGD","LLY","MRK","03165","LU0345777147.USD","LU0171293334.USD","OPK","LU0661504455.SGD","PFE","LU1366192091.USD","LU1015430645.USD","LU2491049909.HKD","GPCR","MTSR","LU0965508806.USD","LU0097036916.USD","LU1066053197.SGD","LU2237443978.SGD","LU0466842654.USD","LU2237443622.USD","LU1280957306.USD","03692","LU2491050154.USD","LU0545039389.USD","AMGN","LU2491050071.SGD","IE00B1XK9C88.USD","LU1941712264.USD","GB00BDT5M118.USD","LU0109391861.USD","SRRK","LU0128525689.USD","LU0238689110.USD","ALT","LU0203347892.USD","LU0471298694.HKD","LU0889566641.SGD","LU0957799991.USD","LU2461242641.AUD","LU0310799852.SGD","LU0985320562.USD","LU0640476718.USD","LU0011850046.USD","VKTX","AZN.UK","LU2357305700.SGD","LU1093756168.USD","LU1162221912.USD","02105"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2579523437","title":"重温稿-美國肥胖症生物技術公司 Metsera 成為諾和、輝瑞競購戰的焦點","url":"https://stock-news.laohu8.com/highlight/detail?id=2579523437","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579523437?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 15:28","pubTimestamp":1761895730,"startTime":"0","endTime":"0","summary":"重温稿-美国肥胖症生物技术公司 Metsera 成为诺和、辉瑞竞购战的焦点重复周四首发的报导，文字不变Bhanvi Satija. 路透伦敦10月31日 - Metsera MTSR.O已成为肥胖症药物市场最热门的产品。Metsera的主要候选药物MET-097i是一种每月一次的GLP-1注射剂。辉瑞的出价包括里程碑在内价值 73 亿美元，而诺和诺德的出价高达 90 亿美元。Viking Therapeutics VKTX.O和Structure Therapeutics GPCR.O分别上涨了9.5%和6%。与 Metsera 的产品相比，它们的治疗方法在研发中处于领先地位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0af834d50c548d8f93896c63d2f96f88","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251031:nL4T3WC0L0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0642271901.SGD","LU0203347892.USD","LU0545039389.USD","LU0251131958.USD","LU0289739699.SGD","IE00BJTD4V19.USD","LU1057294990.SGD","BK4585","LU0061474705.USD","LU0342679015.USD","MTSR","LU0345769128.USD","LU2097344357.USD","LU0306806265.USD","LU0251132253.USD","LU0882574055.USD","LU0792757196.USD","LU2237443382.USD","LU0210533765.USD","LU0130103400.USD","GPCR","IE00BBT3K403.USD","VKTX","SG9999015952.SGD","LU0149725797.USD","LU0234572021.USD","PFE","LU1291159041.SGD","LU0211327993.USD","LU0444973449.USD","LU1868836591.USD","ALT","IE00B19Z3B42.SGD","LU1003077747.HKD","LU1496350171.SGD","BK4592","BK4534","LU0648000940.SGD","LU0077335932.USD","LU1974910355.USD","BK4543","LU2087625088.SGD","LU2505996681.GBP","LU0320765489.SGD","LU0980610538.SGD","BK4588","LU0128525929.USD","LU0345774391.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2579315646","title":"四環醫藥(00460)與美國AbaloneBio簽署合作協議，聯合開發新一代減重增肌創新療法，進一步深化GPCR靶點領域佈局","url":"https://stock-news.laohu8.com/highlight/detail?id=2579315646","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579315646?lang=zh_tw&edition=fundamental","pubTime":"2025-10-30 08:11","pubTimestamp":1761783065,"startTime":"0","endTime":"0","summary":"智通财经APP讯，四环医药 公布，该集团已与美国生物技术公司AbaloneBio正式签署合作协议。根据协议约定，双方将在全球范围内开展协作，共同推进新一代肥胖治疗创新药物的研发工作。此次合作协议的签署，标志着双方合作从资本层面延伸至业务执行层面，将进一步巩固集团在减重领域的创新布局，并借助Abalone的技术优势，加快新一代减重增肌疗法的研发进度，为集团长期战略发展提供支撑。此外，本次合作亦为集团深化GPCR靶点领域布局的重要举措。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1362476.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00460","BK1593","BK1600","BK1515","BK1191","BK4599","BK4007","GPCR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":40,"code":"91000000","status":"200"}]}}